Bergström A L, Bengtsson B A, Olsson L B, Malmvall B E, Kutti J
Ann Rheum Dis. 1979 Jun;38(3):244-7. doi: 10.1136/ard.38.3.244.
Duplicate platelet survival studies were carried out on 8 patients with giant cell arteritis (GCA), once before the institution of any therapy, and the second time when they were in a completely asymptomatic phase after having received corticosteroid treatment. The time interval between the studies ranged between 5 and 14 months. In the first study the mean peripheral platelet count was 486 +/- 25 X 10(9)/l and in the second 326 +/- 25 X 10(9)/l. The difference between the means was highly significant (P less than 0.001). The mean life-span of the platelets was normal in the duplicate experiments (6.7 +/- 0.3 and 7.3 +/- 0.4 days, respectively). Platelet production rate was significantly (P less than 0.001) raised in the first experiment but became normal in response to corticosteroid therapy. It is concluded that the thrombocytosis seen in GCA is reactive to the inflammation present in this disease, and it seems reasonable to assume that the reduction in the peripheral platelet count which occurs in response to corticosteroid therapy accurately reflects the clinical improvement of the patient.
对8例巨细胞动脉炎(GCA)患者进行了重复的血小板存活研究,一次是在开始任何治疗之前,第二次是在他们接受皮质类固醇治疗后处于完全无症状阶段时。两次研究之间的时间间隔为5至14个月。在第一次研究中,外周血小板平均计数为486±25×10⁹/L,第二次为326±25×10⁹/L。均值之间的差异非常显著(P<0.001)。在重复实验中血小板的平均寿命正常(分别为6.7±0.3天和7.3±0.4天)。血小板生成率在第一次实验中显著升高(P<0.001),但在皮质类固醇治疗后恢复正常。结论是,GCA中出现的血小板增多是对该疾病存在的炎症的反应,并且可以合理地假设,皮质类固醇治疗后外周血小板计数的降低准确反映了患者的临床改善。